ClinicalTrials.Veeva

Menu

Effect of Intracanal Medicaments on Post-Operative Pain in Symptomatic Apical Periodontitis: An RCT

H

HITEC-Institute of Medical Sciences

Status

Completed

Conditions

Periodontal Diseases

Treatments

Drug: Modified Triple Antibiotic Paste
Drug: Chlorhexidine Gel (2%)
Drug: Calcium Hydroxide (20%)

Study type

Interventional

Funder types

Other

Identifiers

NCT07123792
Dr Fatimah

Details and patient eligibility

About

Comparison of different intracanal medicaments during root canal treatment to assess their effect on post-operative pain in teeth with Symptomatic Apical Periodontitis

Full description

Pain is the most common clinical symptom associated with endodontic treatment. Symptomatic apical periodontitis (SAP) results in significant post-operative discomfort due to microbial invasion and inflammatory changes in periapical tissues. Intracanal medicaments are used to reduce microbial load and inflammation between treatment appointments, potentially reducing post-treatment pain. This study investigates the comparative effectiveness of three commonly used intracanal medicaments in reducing pain following biomechanical preparation:

Group 1: Calcium hydroxide (CH)

Group 2: Chlorhexidine gel (CHX 2%)

Group 3: Modified Triple Antibiotic Paste (TAP) - a combination of ciprofloxacin, clindamycin, and metronidazole in 1:1:1 ratio

A total of 480 participants with single-rooted teeth diagnosed with symptomatic apical periodontitis will be randomly assigned into three groups (160 in each group). Endodontic treatment will be performed by a single operator under standard protocols. No systemic analgesics or antibiotics will be prescribed. Pain assessment will be done using the Wong-Baker FACES Pain Rating Scale (0-10), and recorded at baseline (0 h), 6 h, 24 h, and 48 h after treatment.

The study aims to provide evidence on the most effective intracanal medicament to minimize post-operative pain, improving patient outcomes and guiding clinical decision-making.

Enrollment

480 patients

Sex

All

Ages

15 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Single rooted teeth (Anterior or posterior)
  • Teeth with acute symptomatic apical periodontitis

Exclusion criteria

  • Non-restorable teeth, presence of endo-perio lesions, teeth with acute or chronic apical abcess, teeth with internal/external root resorption
  • Teeth with anatomical difficulties like open apices, calcified canals, dilacerations
  • Patients with parafunctional habits
  • Patients who were allergic to medications that were used in the study
  • Patients who were taking medicines that could influence pain perception
  • Patients that had any serious medical illness or with systemic disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

480 participants in 3 patient groups

Calcium Hydroxide group
Experimental group
Description:
Participants in this group will receive 20% calcium hydroxide paste as the intracanal medicament after root canal instrumentation. The medicament will be placed using a Lentulo spiral, excess removed from the chamber, and the tooth sealed with glass ionomer cement. Pain will be assessed at 0, 6, 24, and 48 hours postoperatively.
Treatment:
Drug: Calcium Hydroxide (20%)
Chlorhexidine group
Experimental group
Description:
Participants in this group will receive 2% chlorhexidine gel as the intracanal medicament following canal preparation. It will be placed with a Lentulo spiral and sealed in the same manner. Postoperative pain will be evaluated at the same intervals.
Treatment:
Drug: Chlorhexidine Gel (2%)
Modified triple antibiotic paste
Experimental group
Description:
Participants in this group will receive a modified triple antibiotic paste made from ciprofloxacin, metronidazole, and clindamycin in a 1:1:1 ratio by weight. The paste will be placed inside the canal using a Lentulo spiral and sealed as per protocol. Pain will be recorded at 0, 6, 24, and 48 hours post-treatment.
Treatment:
Drug: Modified Triple Antibiotic Paste

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems